Related by context. All words. (Click for frequent words.) 70 elotuzumab 70 Aflibercept 70 cetuximab Erbitux 70 Aliskiren 70 Dasatinib 70 Elotuzumab 69 Boceprevir 69 Alemtuzumab 69 Velcade bortezomib 69 mapatumumab 69 pertuzumab 69 standard chemotherapy regimen 69 Pertuzumab 69 Erlotinib 69 Amrubicin 68 Perifosine 68 Genentech Roche 68 Tavocept 68 Bortezomib 68 evaluating tivozanib 68 Gleevec imatinib mesylate 68 Herceptin trastuzumab 68 Romiplostim 68 docetaxel Taxotere R 68 radiation sensitizer 68 Revlimid lenalidomide 68 ImClone Erbitux 68 Trastuzumab 67 Genentech Rituxan 67 Ambrisentan 67 bevacizumab Avastin 67 Xelox 67 ZOLINZA 67 BRAF inhibitor 67 reslizumab 67 investigational humanized monoclonal antibody 67 Meets Primary Endpoint 67 Vandetanib 67 Allovectin 7 67 anti EGFR antibody 67 YONDELIS 67 Daclizumab 67 MyVax R 67 Irinotecan 67 INCB# [001] 67 IMA# 67 Bevacizumab 67 Cetrorelix 67 ixabepilone 67 Dapagliflozin 67 Zolinza 67 tanespimycin 67 PRT# 67 AEG# 67 Randomized Phase 67 phase IIb trial 67 HuMax CD4 67 Vectibix panitumumab 67 Laquinimod 67 Ixempra 67 proteasome inhibitor 67 Nexavar sorafenib 67 lapatinib Tykerb 67 Temsirolimus 67 Gemzar ® 67 paclitaxel Taxol 67 Pfizer Sutent 67 Viramidine 67 Lenalidomide 67 Varespladib 67 Asentar 66 Archexin 66 pegylated liposomal doxorubicin 66 Glufosfamide 66 AVASTIN 66 Neulasta ® 66 Sorafenib 66 AEGR 66 relapsed ovarian cancer 66 Taxotere chemotherapy 66 erlotinib Tarceva ® 66 Pralatrexate 66 Camptosar ® 66 Golimumab 66 CCX# 66 oxaliplatin Eloxatin 66 Telaprevir 66 Targretin 66 Folotyn 66 virus HCV protease inhibitor 66 HuLuc# 66 GW# [003] 66 MAGE A3 ASCI 66 Degarelix 66 thalidomide Thalomid 66 Epratuzumab 66 Ceflatonin 66 Azedra 66 erlotinib Tarceva 66 IMC A# 66 panitumumab Vectibix 66 Pegloticase 66 Onyx Pharma 66 bevacizumab Avastin ® 66 Nexavar ® 66 corticosteroid dexamethasone 66 Immunotherapeutic 66 zoledronic acid Zometa 66 sipuleucel T 65 DU #b 65 MT#/MEDI-# 65 Tanespimycin 65 Gemcitabine 65 volociximab 65 sunitinib malate 65 IMC #B 65 Tezampanel 65 mertansine 65 TOCOSOL Paclitaxel 65 gefitinib Iressa 65 HGS ETR1 65 teriflunomide 65 Blinatumomab 65 sorafenib Nexavar 65 Novartis Zometa 65 FOLOTYN ® 65 PF # [002] 65 ASA# 65 LAF# 65 Bezielle 65 JAK inhibitor 65 Peginterferon alfa 2b 65 Civacir 65 Clofarabine 65 oral ridaforolimus 65 Taxotere docetaxel 65 HuMax EGFr 65 EndoTAG TM -1 65 Maribavir 65 liposomal formulation 65 SPRYCEL ® 65 Alkeran 65 Xeloda ® 65 Ofatumumab 65 HGS ETR2 65 oral prodrug 65 Fulvestrant 65 Taxotere ® 65 dasatinib Sprycel 65 XmAb# 65 PSMA ADC 65 UPLYSO 65 Celgene Revlimid 65 Tesmilifene 65 ganetespib 65 antibody MAb 65 SAR# [004] 65 Muraglitazar 65 Vitaxin 65 dacetuzumab 65 Erbitux cetuximab 65 OncoVEX GM CSF 65 Phase 2b Clinical Trial 65 Tarceva TM 65 aflibercept 65 Xanafide 65 Trastuzumab DM1 65 Bafetinib 65 axitinib 64 Bicifadine 64 Epidermal Growth Factor Receptor 64 Pemetrexed 64 Vicriviroc 64 infusional 5-FU/LV 64 Tykerb lapatinib 64 Pazopanib 64 IgG1 monoclonal antibody 64 Hematological Malignancies 64 Campath alemtuzumab 64 ularitide 64 Panzem 64 Regeneron Pharma 64 Canvaxin 64 adalimumab Humira 64 alpha 2a 64 Panzem R NCD 64 Dalbavancin 64 rituximab Rituxan 64 regorafenib 64 IL# PE#QQR 64 Hycamtin 64 Tarvacin 64 CIMZIA TM 64 etanercept Enbrel 64 thymalfasin 64 midstage trials 64 chemotherapy FOLFOX 64 Syncria 64 Jevtana 64 TRX1 64 Phase #b/#a clinical 64 Roche Actemra 64 Onconase 64 docetaxel Taxotere ® 64 Egrifta 64 HGS# 64 iniparib 64 cetuximab Erbitux R 64 investigational monoclonal antibody 64 BAY #-# 64 Pirfenidone 64 Uvidem 64 Taxol paclitaxel 64 Carfilzomib 64 IRX 2 64 Hormone Refractory Prostate Cancer 64 Zarnestra 64 paclitaxel Taxol ® 64 Arixtra 64 PDE4 inhibitor 64 custirsen 64 Pegintron 64 Deforolimus 64 Saforis 64 Paraplatin ® 64 MGd 64 gemcitabine Gemzar 64 TMC# [002] 64 receptor tyrosine kinase inhibitor 64 HuMax CD# 64 imatinib Gleevec ® 64 Cetuximab Erbitux 64 sorafenib tablets 64 darapladib 64 TYZEKA 64 alvespimycin 64 5 Fluorouracil 64 CR# vcMMAE 64 phase IIb III 64 Antitumor Activity 64 BRIM2 64 vandetanib 64 cediranib 64 Adentri 64 GlaxoSmithKline Tykerb 64 Anti Tumor 64 Eltrombopag 64 huC# DM4 64 Achieves Primary Endpoint 64 Pivotal Phase 64 monoclonal antibody IgG1 Mab 64 lumiliximab 64 atrasentan 64 Initiates Phase III 64 Patient Enrollment 64 TLK# 64 rilonacept 64 pomalidomide 64 Ocrelizumab 64 Neoadjuvant 64 KRAS mutation 64 trastuzumab Herceptin R 64 Leukine 64 anticancer therapy 64 dasatinib Sprycel ® 64 antiplatelet agent 64 T DM1 64 YERVOY 64 Exemestane 64 gemcitabine chemotherapy 64 vemurafenib 64 Mipomersen 64 Fludara ® 64 BZL# 64 Roche Xeloda 64 Eribulin 64 Reverset 64 Phase IIb Trial 64 FASLODEX 64 Combination REOLYSIN R 64 Iloperidone 64 Completes Patient Enrollment 64 LEP ETU 64 canakinumab 64 atacicept 64 Seattle Genetics SGEN 64 CDP# 63 Liraglutide 63 metaglidasen 63 Ustekinumab 63 #D#C# 63 OvaRex ® MAb 63 Amgen Vectibix 63 Natalizumab 63 Vectibix 63 alfa 2a 63 pegylated interferons 63 neratinib 63 Arranon 63 Telbivudine 63 HER2 positive metastatic breast 63 efalizumab 63 Vidaza azacitidine 63 Sanofi Aventis Taxotere 63 Ixabepilone 63 perampanel 63 PSN# [002] 63 Safinamide 63 NDA Submission 63 interferon gamma 1b 63 pemetrexed Alimta 63 Amplimexon 63 Tocosol Paclitaxel 63 Dendreon Provenge 63 docetaxel Taxotere 63 ocrelizumab 63 Rituxan rituximab 63 baminercept 63 enzastaurin 63 HDAC Inhibitor 63 Cardiotoxicity 63 OMP #R# 63 invasive candidiasis 63 lomitapide 63 Paraplatin 63 dasatinib 63 ELND# 63 OSI Pharma 63 capecitabine Xeloda 63 Cladribine 63 Luveris 63 IND Filing 63 TroVax ® 63 NV1FGF 63 Factor VIIa 63 JAK Inhibitor 63 Zometa zoledronic acid 63 Avastin bevacizumab 63 Phase III Trial 63 Onyx Pharmaceuticals Announces 63 Ozarelix 63 ISTODAX 63 Telcyta 63 Neurodex 63 Factor Xa inhibitor 63 Tipranavir 63 FOLFIRI 63 Virulizin ® 63 LymphoStat B belimumab 63 Cinquil 63 HCD# [002] 63 MetMAb 63 Interferon Beta 63 Treanda 63 Campath ® 63 gemcitabine Gemzar R 63 Panzem R 63 trastuzumab Herceptin 63 NVA# 63 PEG SN# 63 Vidofludimus 63 MKC# MT 63 sitaxsentan 63 metastatic castration resistant 63 protein kinase inhibitor 63 oral FTY# 63 Telatinib 63 Pioglitazone 63 telaprevir VX 63 LymphoStat B TM 63 APTIVUS 63 QVA# 63 Voreloxin 63 CoFactor 63 Clolar ® 63 Lacosamide 63 BRIM3 63 ZK EPO 63 Severe Sepsis 63 Hsp# Inhibitor 63 Acapodene 63 Novartis Gleevec 63 Annamycin 63 vorinostat 63 letrozole Femara 63 Apixaban 63 Neuvenge 63 TEMODAL 63 drug conjugate 63 Abatacept 63 ADP receptor antagonist 63 deforolimus 63 Pixantrone 63 oncolytic virus therapies 63 Vertex hepatitis C 63 Alfimeprase 63 Hepatocellular Carcinoma HCC 63 trastuzumab DM1 63 small molecule tyrosine 63 Talabostat 63 PANVAC VF 63 Amigal 63 STRIDE PD 63 EGFR inhibitors 63 Panzem NCD 62 Bicalutamide 62 platelet inhibitor 62 PLK1 SNALP 62 Advanced Melanoma 62 metastatic renal cell carcinoma 62 Stimuvax R 62 Tarceva erlotinib 62 anti angiogenic agent 62 AstraZeneca Iressa 62 Elagolix 62 Pivotal Phase III 62 Ticagrelor 62 Capecitabine 62 Abiraterone 62 Aptivus ® 62 Immunogen 62 Saxagliptin 62 Eraxis 62 ONGLYZA ™ 62 Ridaforolimus 62 R sorafenib tablets 62 tesmilifene 62 Dacogen decitabine 62 cisplatin vinorelbine 62 GSK# [002] 62 Vernakalant 62 Alvine Pharmaceuticals 62 TELINTRA 62 MEK Inhibitor 62 Genentech Herceptin 62 selective androgen receptor modulator 62 histone deacetylase HDAC inhibitor 62 cetuximab Erbitux ® 62 BEXXAR 62 posaconazole 62 Allovectin 7 ® 62 MyVax 62 CD# monoclonal antibody 62 motesanib 62 CIMZIA ™ 62 refractory chronic lymphocytic 62 Marqibo TM 62 mTOR inhibitor 62 FOLFOX6 chemotherapy regimen 62 RANK Ligand inhibitor 62 ATL/TV# 62 Traficet EN 62 L BLP# 62 Gleevec resistant 62 GVAX 62 Mitoxantrone 62 anticancer compound 62 otelixizumab 62 Tyrima 62 TroVax 62 paroxetine Paxil 62 Azixa 62 ACAPODENE 62 Milestone Payment 62 ATL# [001] 62 Mepact 62 Nanobody 62 metastatic hormone refractory 62 amrubicin 62 LHRH antagonists 62 Virulizin R 62 TORISEL 62 Fabry Disease 62 Arcalyst 62 Hepatocellular Carcinoma 62 inhibitor RG# 62 Valsartan 62 Tasigna nilotinib 62 Proxinium TM 62 antibody MT# 62 NXL# 62 celgosivir 62 Gliadel Wafer 62 Granulocyte Colony Stimulating Factor 62 Noxafil 62 Firazyr 62 LY# [003] 62 Rivaroxaban 62 Febuxostat 62 SUTENT ® 62 dexpramipexole 62 sunitinib Sutent ® 62 Arzerra 62 PTK ZK 62 Oral Fingolimod 62 Imprime PGG 62 anti CD# antibodies 62 Oxaliplatin 62 liposomal doxorubicin 62 lintuzumab 62 Antiangiogenic 62 Torisel 62 Troxatyl 62 Pimavanserin 62 Quinamed 62 decitabine 62 Sapacitabine 62 DXL# 62 Glatiramer Acetate 62 Ceftaroline 62 Neupogen ® 62 Epivir 62 R#/MEM 62 Thiarabine 62 ONCONASE R 62 Eli Lilly Gemzar 62 FOLFOX6 62 CD# antibody [001] 62 docetaxel chemotherapy 62 Votrient 62 PEGylated Fab fragment 62 Copegus ribavirin 62 VEGF Trap 62 ZADAXIN ® 62 Pradefovir 62 xanthine oxidase inhibitor 62 pan HDAC inhibitor 62 Entecavir 62 Sym# 62 terlipressin 62 Initiate Phase 62 Onco TCS 62 sodium glucose cotransporter 62 R lenalidomide 62 Tofacitinib 62 Vorapaxar 62 elinogrel 62 metastatic malignant 62 phase IIb clinical 62 Novel Oral 62 panitumumab 62 Navelbine ® 62 PROCHYMAL 62 Intravenous CP 62 DOXIL 62 CCX# B 62 Numax 62 Maraviroc 62 Ganciclovir 62 temsirolimus 62 Prolongs Survival 62 ALN PCS 62 Aplidin 62 INCB# [003] 62 Roche Pegasys 62 Avanafil 62 Xinlay 62 CYT# potent vascular disrupting 62 Cethromycin 62 alemtuzumab Campath 62 micafungin 62 STELARA TM 62 EndoTAGTM 1 62 PKC# 62 Nuvion 62 Malignant Melanoma 62 Hycamtin ® 62 Olaparib 62 Vilazodone 62 uric acid lowering 62 Darusentan 62 RhuDex 62 Radezolid 62 Cloretazine ® 62 glufosfamide 62 VAPRISOL 62 Investigational Compound 62 Initiates Enrollment 62 Initiates Clinical 62 oral cladribine 62 phase IIb 62 DCVax R 62 KNS # 62 TLR9 agonist 62 Tumor Response 62 Aptivus 62 rasagiline tablets 62 danoprevir 62 DEB# 62 MAXY G# 62 Valopicitabine 62 Allovectin 7 R 62 Medoxomil 62 dirucotide 62 Sprycel dasatinib 62 Aurora Kinase 62 Angiocept 62 Ontak 62 Xenazine ® 62 cinacalcet HCl 62 ASONEP 62 Gastrointestinal Stromal Tumors 62 abatacept Orencia 62 orBec 61 TBC# 61 IV Busulfex 61 Resten NG 61 Rilonacept 61 Xcytrin R 61 targeted radiotherapeutic 61 adecatumumab 61 Fludarabine 61 Adjuvant Therapy 61 glatiramer 61 FOLFOX chemotherapy 61 midstage studies 61 Rebetol 61 Calcitonin 61 Lisofylline 61 Afatinib 61 CBLC# 61 p# biomarker 61 Glaxo Tykerb 61 valopicitabine 61 CTAP# Capsules 61 DexaSite 61 Pafuramidine 61 Phase 2a Trial 61 muraglitazar 61 DPX Survivac 61 Aplidin R 61 Sanvar 61 selective modulator 61 Adalimumab 61 OHR/AVR# 61 MEVACOR 61 Apaziquone 61 MYDICAR ® 61 Evoltra 61 sargramostim 61 Orally administered 61 Vivecon 61 T#I [002] 61 Orazol 61 trastuzumab DM1 T DM1 61 TELCYTA 61 tyrosine kinase inhibitor 61 oral salmon calcitonin 61 Personalized Immunotherapy 61 Plicera 61 Phase III Clinical Trial 61 MKC# MKC# PP 61 Roche Avastin 61 Xyfid TM 61 Efficacy Results 61 Presents Preclinical 61 bortezomib Velcade 61 APOPTONE 61 Chronic Hepatitis C 61 myelofibrosis polycythemia vera 61 mycophenolate mofetil 61 rNAPc2 61 Tesetaxel 61 Platinol ® cisplatin 61 Mycamine 61 cancer immunotherapies 61 anti CD3 antibody 61 RIGScan CR 61 LUCENTIS 61 EFAPROXYN 61 Rituximab 61 Milatuzumab 61 mRCC 61 tocilizumab 61 HQK 61 BCR ABL inhibitor 61 CAELYX 61 PEGylated interferon 61 IAP inhibitors 61 DPP4 61 EGS# 61 Clinical Trial Results 61 calcineurin inhibitors 61 Bayer Nexavar 61 oral proteasome inhibitor 61 PEG INTRON 61 cilengitide 61 Drug Candidate 61 PrevOnco 61 Tacrolimus 61 ridaforolimus 61 Bevacizumab Avastin 61 TNF Tumor Necrosis Factor 61 Davanat 61 Bavituximab 61 ALN TTR 61 pegylated interferon alpha 61 eniluracil 61 Vertex telaprevir 61 HSP# inhibitor 61 taxane chemotherapy 61 5 FU leucovorin 61 NSABP C 61 Hedgehog Pathway Inhibitor 61 lenalidomide Revlimid R 61 Merck KGaA Erbitux 61 Thalomid ® 61 investigational immunotherapy 61 evaluating Xcytrin 61 IGF 1R inhibitor 61 amifostine 61 Radioimmunotherapy 61 Isis Pharma 61 Rilutek 61 multi kinase inhibitor 61 ACTEMRA TM 61 talabostat 61 Aviptadil 61 Elesclomol 61 ZACTIMA 61 REBETOL combination therapy 61 Insegia 61 eritoran 61 ACZ# 61 Anthracycline 61 PS# [001] 61 Squalamine 61 glatiramer acetate 61 pioglitazone HCl 61 mesylate 61 Doxil 61 YONDELIS R 61 TREANDA 61 Patients Treated With 61 Eculizumab 61 thetreatment 61 Novantrone 61 acyclovir Lauriad R 61 Fablyn 61 Octreotide 61 Pivotal Trial 61 Folfox 61 novel nucleoside analog 61 TYKERB 61 PROSTVAC TM 61 Omacetaxine 61 Thiovir 61 luteinizing hormone releasing 61 polymerase inhibitor 61 Pivotal Clinical Trial 61 PHX# 61 MORAb 61 Phase 2a Clinical Trial 61 MNTX 61 Vion Pharmaceuticals 61 nucleoside reverse transcriptase inhibitor 61 Onalta 61 tenofovir Viread 61 XELOX 61 Fingolimod 61 PRN FDA Approves 61 pradefovir 61 bortezomib Velcade ® 61 interferon alfa 61 APTIVUS r 61 investigational protease inhibitor 61 CINTREDEKIN BESUDOTOX 61 sunitinib Sutent 61 Optimer Pharma 61 tumor vascular disrupting 61 humanized antibody 61 assessing T DM1 61 OncoVex 61 Bucindolol 61 Trabectedin 61 Etanercept 61 gemcitabine carboplatin 61 Tumor Necrosis Factor 61 chimeric monoclonal antibody 61 Kepivance 61 Milestone Payment From 61 Roche Herceptin 61 forodesine 61 ISIS # 61 Docetaxel 61 POTELLIGENT R Technology 61 methylnaltrexone bromide 61 Generic Version 61 selective kinase inhibitor 61 TACI Ig 61 canagliflozin 61 Carvedilol 61 APPRAISE 61 Betaseron ® 61 ProSavin 61 Metastatic Melanoma 61 VNP#M 61 PSN# [001] 61 SNT MC# 61 Azacitidine 61 Decitabine 61 Zorbtive TM 61 FLT3 61 Seliciclib 61 monoclonal antibody MAb 61 Gefitinib 61 RELOVAIR ™ 61 SAR# [002] 61 Cimzia TM 61 Caelyx 61 compound INCB# 61 AZILECT R 61 LymphoStat B 61 Xyotax 61 Vidaza ® 61 Removab 61 Promacta 61 Mg Usa 61 CD3 monoclonal antibody 61 RAPTIVA 61 maribavir 61 gastrointestinal stromal tumors 61 Denosumab 61 CYC# 61 Diamyd ® 61 Certolizumab 61 Gleevec Glivec 61 registrational trial 61 INTELENCE 61 Pooled Analysis 61 Ceflatonin R 61 PegIntron 61 omalizumab Xolair 61 metastatic colorectal 61 bortezomib Velcade R 61 TOLAMBA 61 PD LID 61 Gilead Viread 61 Dificid 61 Phase III Pivotal 61 Antibody Drug Conjugate 61 Interferon alpha 61 OSI Tarceva 61 Rheumatoid Arthritis Drug 61 vismodegib 61 daclizumab 60 TNF blocker 60 Milestone Payments 60 ® bortezomib 60 alpha folate receptor 60 Leukine ® 60 Abraxane 60 EOquin TM 60 soluble tumor necrosis 60 MYDICAR 60 tremelimumab 60 Biogen Avonex 60 Antiviral Activity 60 Omapro 60 OPAXIO 60 Angiolix 60 ATACAND 60 Mirapexin 60 Zactima 60 Ceflatonin ® 60 AeroLEF TM 60 relapsing multiple sclerosis 60 Candesartan 60 tipifarnib 60 Advexin 60 alvimopan 60 PEG interferon 60 Initiates Phase II 60 DAVANAT 60 PEGINTRON TM 60 Diabetic Macular Edema 60 Teriflunomide 60 HCV protease inhibitor 60 Liprotamase 60 Argatroban 60 Satraplatin 60 Peregrine Pharma 60 vosaroxin 60 SUTENT 60 COPEGUS 60 StaphVAX 60 Vidaza R 60 lenalidomide dexamethasone 60 orally bioavailable 60 RECOTHROM R 60 Brentuximab Vedotin SGN 60 Renal Cell Carcinoma 60 selective orally bioavailable 60 Dabigatran etexilate 60 PARP inhibitor 60 Pegylated Liposomal Doxorubicin 60 FUSILEV ® 60 trabectedin 60 Fibrin Pad 60 RhuDex R 60 MabCampath 60 HuMax 60 Vfend 60 Auxilium Pharma 60 Nanobody ® 60 Aurexis 60 lexidronam injection 60 Naproxcinod 60 Aceon 60 Theratope 60 Starlix 60 Phase 1b clinical trials 60 nucleoside analog 60 tafamidis 60 brostallicin 60 Pivotal Study 60 galiximab 60 bosutinib 60 BrachySil 60 Bayer Onyx 60 Gleevec imatinib 60 Campath 60 Ipilimumab 60 nilotinib Tasigna 60 Corlux 60 AMN# [001] 60 Randomized Double blind 60 TREDAPTIVE 60 PEGylated interferon beta 1a 60 Femara letrozole 60 tenofovir emtricitabine 60 Faslodex 60 estramustine 60 AZT zidovudine Retrovir 60 targeting CD# 60 Heplisav 60 refractory gout 60 Stedivaze 60 AERx iDMS 60 A3 adenosine receptor 60 ® lenalidomide 60 novel VDA molecule 60 IgG1 antibody 60 PROMACTA 60 anidulafungin 60 XL# anticancer compounds 60 TOCOSOL Camptothecin 60 ALN HPN 60 albiglutide 60 BRAF inhibitors 60 Belinostat 60 ZEVALIN ® 60 LHRH antagonist 60 Myelodysplastic Syndrome MDS 60 Orencia abatacept 60 Elvitegravir 60 diabetic neuropathic pain 60 Amlodipine Besylate 60 cladribine 60 MAA submission 60 IMiDs 60 Psoriasis Drug 60 Combidex 60 HoFH 60 Prednisporin 60 proteasome inhibitors 60 ReoPro 60 RG# [001] 60 Everolimus 60 AzaSite Plus 60 rilpivirine 60 beta 1a 60 QuadraSphere 60 Phase Ib clinical 60 Sipuleucel T 60 evaluating satraplatin 60 Tamibarotene 60 severe hypercholesterolemia 60 obatoclax 60 lucinactant 60 Interferon alfa 60 Junovan 60 AMEVIVE 60 Milnacipran 60 relapsed MM 60 Liposomal 60 Initiates Clinical Trial 60 Tocilizumab 60 Enzastaurin 60 Myocet 60 INTEGRILIN 60 Sustiva efavirenz 60 Doxil ® 60 Cancidas 60 Nipent R 60 non peptidic protease 60 Torisel temsirolimus 60 Biomarker Study 60 Ranolazine